Med Page Today

MAY 11, 2024

(MedPage Today) -- NEW ORLEANS -- A "culturally sensitive" exercise intervention led to weight loss and other benefits in African-American women with obesity at risk for diabetes, researchers reported. The program tested in the ongoing, single.

Obesity 77

Obesity Exercise Diabetes Research 77

CardiacWire

JANUARY 22, 2025

To tackle this problem, researchers compared Veterans Affairs data on 2 million T2D patients (2017-2023) taking either GLP-1s , DPP4is, SGLT2is, or usual care antihyperglycemics over a 3.68 That said, it could serve as an early look into the long-term health outcomes of using GLP-1s to treat obesity and T2D. year follow-up.

Obesity 59

Obesity Cardiac Arrest Dementia Outcomes 59

American Heart News - Heart News

NOVEMBER 11, 2024

Research Highlights: Heart disease, Type 2 diabetes, high blood pressure and obesity were more common and linked to reduced access to healthy food among people who lived in neighborhoods previously subjected to structural racism-based policies that.

Heart Disease 106

Heart Disease Blood Pressure Obesity Diabetes 106

Cardiovascular Diabetology

SEPTEMBER 11, 2024

Cardiovascular disease represents a significant risk factor for mortality in individuals with type 2 diabetes mellitus (T2DM). High-density lipoprotein (HDL) is believed to play a crucial role in maintaining c.

Obesity 130

Obesity Risk Factors Cardiovascular Disease Diabetes 130

DAIC

AUGUST 15, 2024

13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for many Americans, according to a study led by UT Southwestern Medical Center researchers and published in JAMA Cardiology. Ann Marie Navar, M.D., tim.hodson Thu, 08/15/2024 - 10:32 Aug. population. Eric Peterson, M.D.,

Heart Disease 105

Heart Disease Research Cholesterol Public Health 105

CardiacWire

MAY 8, 2024

Officially published by the AHA six months ago, CKM syndrome defines the connections and risks associated with obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease. The researchers analyzed 2011-2020 NHANES survey results and laboratory measurements from 10,762 nationally representative US adults (47.3yr avg.

Kidney Disease 116

Kidney Disease Obesity Risk Factors Diabetes 116

Medical Xpress - Cardiology

APRIL 2, 2024

Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers at the Broad Institute of MIT and Harvard along with Massachusetts General Hospital has found that microbes in the gut may affect cardiovascular disease as well.

Heart Disease 104

Heart Disease Obesity Cardiovascular Disease Diabetes 104

DAIC

JUNE 18, 2024

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8

Heart Disease 105

Heart Disease Blood Pressure Stroke Strokes 105

Medical Xpress - Cardiology

JANUARY 9, 2025

For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows. However, with price reductions or rebates up to 50%, it could meet the benchmark for value in health care.

Diabetes 59

Diabetes Obesity Cardiovascular Disease Research 59

Cardiovascular Diabetology

JUNE 28, 2024

The atherogenic index of plasma (AIP) is closely associated with the onset of diabetes, with obesity being a significant risk factor for type 2 diabetes mellitus (T2DM). However, the association between the AI.

Obesity 52

Obesity Diabetes Risk Factors Research 52

CardiacWire

FEBRUARY 11, 2024

The associations between obesity and hypertension are widely known, but a new JACC study reveals that weight-reducing gastric bypass surgery has a significant and lasting impact on patients’ need for antihypertensives. The GATEWAY trial assigned 100 participants (76% women, 43.8 of them achieved BPs below 130/80 mm Hg (vs.

Hypertension 111

Hypertension Blood Pressure Obesity BMI 111

Cardiovascular Diabetology

APRIL 28, 2024

The GLP-1 receptor agonist liraglutide is used to treat hyperglycemia in type 2 diabetes but is also known to induce weight loss, preserve the beta cell and reduce cardiovascular risk. The mechanisms underlyin.

Diabetes 64

Diabetes Obesity Research 64

Cardiovascular Diabetology

MARCH 7, 2025

Obesity and abnormal lipid metabolism increase the risk of various cardiometabolic diseases, including diabetes, heart disease, and stroke. However, the impact of abdominal obesity (AO) and non-traditional lip.

Obesity 52

Obesity Heart Disease Diabetes Stroke 52

Cardiovascular Diabetology

JUNE 17, 2024

Despite the high burden of obesity and Type 2 diabetes (T2DM) in the Middle East/West Asia region, the effect of weight change on the development of T2DM is poorly addressed. Therefore, we aimed to assess the.

Diabetes 59

Diabetes Obesity Research 59

Dr. Paddy Barrett

DECEMBER 13, 2024

Visceral Fat & Insulin Resistance While rates of smoking have decreased significantly in recent decades, the rates of obesity and excess visceral fat have increased dramatically 3. Trends in the number of obese and severely obese people by region. Relationship of BMI and Risk Of Diabetes. Losing 6.5%

Heart Disease 98

Heart Disease BMI Diabetes Cardiovascular Disease 98

Cardiovascular Diabetology

JANUARY 12, 2025

The prevalence of obesity and type 2 diabetes mellitus (T2DM) is rising globally, particularly among children exposed to adverse intrauterine environments, such as those associated with gestational diabetes me.

Diabetes 52

Diabetes Obesity Research 52

Cardiovascular Diabetology

FEBRUARY 16, 2025

Obesity is common in the heart failure (HF) population and is regarded as an important risk factor for developing HF. Greater skeletal muscle mass has shown to be the underlying protective factor against cardi.

Heart Failure 52

Heart Failure Obesity Risk Factors Diabetes 52

Cardiovascular Diabetology

FEBRUARY 13, 2025

Cardiac autonomic neuropathy (CAN) is a life-threatening complication of diabetes. While obesity is a well-known risk factor of dysautonomia, the association between CAN and body fat distribution has not been.

Diabetes 52

Diabetes Obesity Risk Factors Research 52

Cardiovascular Diabetology

DECEMBER 12, 2023

The association between obesity indicators and mortality in individuals with diabetes remains unclear, and data on cardiovascular mortality are scarce. Therefore, we investigated the associations between the f.

Obesity 40

Obesity Diabetes Research 40

Cardiometabolic Health Congress

JUNE 24, 2024

As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.

Patient Care 52

Patient Care Obesity Education CME 52

Cardiovascular Diabetology

JANUARY 2, 2024

Obesity has increased in recent years with consequences on diabetes and other comorbidities. Thus, 1 out of 3 diabetic patients suffers cardiovascular disease (CVD). The network among glucose, immune system, e.

Obesity 66

Obesity Cardiovascular Disease Diabetes Research 66

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Research has been conducted previously on rtPA exclusion in obese AIS patients as well as AIS patients with a history of smoking [3, 4, 5, 6]. However, little is known regarding the comorbidities associated with exclusion from rtPA in obese AIS patients with a history of smoking.

Obesity 40

Obesity Stroke Strokes Risk Factors 40

Journal of the American Heart Association

FEBRUARY 14, 2024

Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovascular disease, cognitive impairment, and frailty also share the following risk factors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.

Cardiovascular Disease 73

Cardiovascular Disease Dementia Obesity Risk Factors 73

Cardiometabolic Health Congress

OCTOBER 18, 2024

Sleep and Cardiometabolic Risk Dr. Somers delves into the growing body of research connecting poor sleep with heightened cardiometabolic risk. There is a clear relationship between sleep deprivation and the development of conditions like obesity, diabetes, and hypertension.

Blood Pressure 97

Blood Pressure Diabetes Blog Obesity 97

Cardiovascular Diabetology

MARCH 21, 2025

Epicardial adipose tissue (EAT), favored by diabetes and obesity, was shown to co. Heart failure (HF) with preserved ejection fraction (HFpEF) is increasingly prevalent worldwide due to aging and comorbidities.

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Obesity Diabetes 52

Frontiers in Cardiovascular Medicine

FEBRUARY 4, 2024

Recent research has highlighted the significance of MAM, which serve as a platform for various protein molecules, in processes such as calcium signaling, ATP production, mitochondrial structure and function, and autophagy.

Pharmacology 69

Pharmacology Obesity Heart Failure Diabetes 69

Cardiovascular Diabetology

AUGUST 9, 2024

A compromised cardiac autonomic function has been found in subjects with insulin resistance related disorders such as obesity, impaired glucose tolerance (IGT) and type 2 diabetes and confers an increased risk.

Diabetes 40

Diabetes Obesity Research 40

Frontiers in Cardiovascular Medicine

MARCH 6, 2024

Research conducted over the years has led to the modification of definition and classification of cardiomyopathy. However, research into KLFs in cardiomyopathy is still in its early stages, and the pathophysiologic mechanisms of some KLF members in various types of cardiomyopathies remain unclear.

Cardiomyopathy 59

Cardiomyopathy Diabetes Article Obesity 59

European Journal of Heart Failure

DECEMBER 7, 2023

Increasing severity of obesity is associated with multiple characteristics that may contribute to the development or worsening of heart failure (HF) with preserved ejection fraction (HFpEF). Echocardiography demonstrated increased CO with obesity, but not estimated right atrial (RA) pressure or E/e′. Overall, 60.9%

Preserved Ejection Fraction 40

Preserved Ejection Fraction Obesity Heart Failure BMI 40

Cardiovascular Diabetology

AUGUST 21, 2024

Metabolic clusters can stratify subgroups of individuals at risk for type 2 diabetes mellitus and related complications. Since obesity and insulin resistance are closely linked to alterations in hemostasis, we.

Obesity 52

Obesity Diabetes Research 52

Cardiovascular Diabetology

DECEMBER 18, 2024

Whether prediabetes merits particular clinical attention beyond the management of associated risk factors is controversial, particularly given the expansion of the definition of prediabetes from HbA1c 6.06.

Obesity 52

Obesity Risk Factors Diabetes Research 52

Physiologically Speaking

FEBRUARY 14, 2025

They had lower risks of hypertension, diabetes, dementia, stroke, Parkinson’s disease, obesity, sleep apnea, and other chronic health conditions compared to inactive adults and similar risks compared to adults accruing their weekly exercise in a greater number of days. But a new study from Tripp et al.

Physiology 85

Physiology Exercise Research Dementia 85

Cardiometabolic Health Congress

JUNE 7, 2024

Untangling the Statins and Diabetes Link : Dr. Savitha Subtamaniam explored the incidence of diabetes associated with statin use, noting that the mechanism is unclear. She also highlighted uncertainty regarding whether statins worsen glycemic management in individuals with pre-existing diabetes.

Cardiovascular Disease 59

Cardiovascular Disease Obesity Heart Disease Risk Factors 59

DAIC

FEBRUARY 29, 2024

Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73 rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Science Daily - Heart Disease

NOVEMBER 13, 2023

Semaglutide reduced cardiovascular events by 20% in adults with overweight or obesity and established cardiovascular disease who do not have diabetes, according to new research. In the trial, patients treated with semaglutide lost an average of 9.4%

Obesity 40

Obesity Cardiovascular Disease Diabetes Risk Factors 40

Physiologically Speaking

DECEMBER 27, 2023

The quest to determine whether plant-based diets surpass omnivorous diets in their heart healthfulness has been ongoing for decades, yielding inconclusive results despite dedicated research endeavors. Recent research underscores the critical role of gene-nutrient interactions — so-called nutrigenomics.

Diet 69

Diet Cardiovascular Disease Research Diabetes 69

Cardiometabolic Health Congress

AUGUST 14, 2024

The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, driven by lifestyle and health factors. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. When I heard of his passing, I felt quite sad.

CME 72

CME Education Diabetes Innovation 72